相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。COVID-19 and the cardiovascular system
Ying-Ying Zheng et al.
NATURE REVIEWS CARDIOLOGY (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19
Peng Zhang et al.
CIRCULATION RESEARCH (2020)
Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors
Iziah E. Sama et al.
EUROPEAN HEART JOURNAL (2020)
SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?
Gabriela M. Kuster et al.
EUROPEAN HEART JOURNAL (2020)
COVID-19 and heart failure: from infection to inflammation and angiotensinIIstimulation. Searching for evidence from a new disease
Daniela Tomasoni et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
Safiya Richardson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
Giacomo Grasselli et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Conducting sensitivity analysis for unmeasured confounding in observational studies using E-values: The evalue package
Ariel Linden et al.
STATA JOURNAL (2020)
Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China
Juyi Li et al.
JAMA CARDIOLOGY (2020)
Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19
Giuseppe Mancia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19
Harmony R. Reynolds et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
Muthiah Vaduganathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Renin-Angiotensin System Blockers and the COVID-19 Pandemic At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
A. H. Jan Danser et al.
HYPERTENSION (2020)
SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?
Gabriela M. Kuster et al.
EUROPEAN HEART JOURNAL (2020)
Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors
Iziah E. Sama et al.
EUROPEAN HEART JOURNAL (2020)
Semantic computational analysis of anticoagulation use in atrial fibrillation from real world data
Daniel M. Bean et al.
PLOS ONE (2019)
CogStack - experiences of deploying integrated information retrieval and extraction services in a large National Health Service Foundation Trust hospital
Richard Jackson et al.
BMC MEDICAL INFORMATICS AND DECISION MAKING (2018)
MIMIC-III, a freely accessible critical care database
Alistair E. W. Johnson et al.
SCIENTIFIC DATA (2016)
Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors
Raphael N. Vuille-dit-Bille et al.
AMINO ACIDS (2015)
Should ethnicity serve as the basis for clinical trial design? Importance of race/ethnicity in clinical trials - Lessons from the African-American Heart Failure Trial (A-HeFT), the African-American Study of Kidney Disease and Hypertension (AASK), and the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
AL Taylor et al.
CIRCULATION (2005)
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury
K Kuba et al.
NATURE MEDICINE (2005)
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Y Imai et al.
NATURE (2005)
Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy -: The LIFE study
S Julius et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
分享论文
